Sergio Quezada

Sergio Quezada

Company: Achilles Therapeutics

Job title: Chief Scientific Officer


Overcoming Neoantigen Screening Bottlenecks & Empowering Neoantigen Predictions for Expansion of Neoantigen Reactive TILs 1:05 pm

Many TIL developers face bottlenecks in screening for neoantigens and predicting immunogenicity and selectivity potential of discovered neoantigens, which exasperates manufacturing timelines. This workshop discusses solutions and current advancements to expedite processes, crucial for advancing TIL therapy development amidst burgeoning demand. Join this workshop to: Discuss the challenge of intratumor heterogeneity and tools for targeting…Read more

day: Pre-Conference Workshop Day

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.